Larry Rodman
Technik-/Wissenschafts-/F&E-Leiter bei Lewis & Clark Pharmaceuticals, Inc.
Profil
Larry Rodman is currently the Chief Science Officer at Lewis & Clark Pharmaceuticals, Inc. He started this position in 2014.
Dr. Rodman previously worked as a Scientist at Sanofi-Aventis U.S.
LLC.
Aktive Positionen von Larry Rodman
| Unternehmen | Position | Beginn |
|---|---|---|
Lewis & Clark Pharmaceuticals, Inc.
 Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2012 |
Ehemalige bekannte Positionen von Larry Rodman
| Unternehmen | Position | Ende |
|---|---|---|
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Lewis & Clark Pharmaceuticals, Inc.
Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | Retail Trade |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
